SAMSUNG PHARM. Co., LTD. (KRX:001360)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,803.00
+170.00 (10.41%)
Mar 5, 2026, 3:30 PM KST
13.47%
Market Cap 153.70B
Revenue (ttm) 44.29B
Net Income (ttm) 12.71B
Shares Out 94.12M
EPS (ttm) n/a
PE Ratio 12.09
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,578,552
Average Volume 3,188,410
Open 1,648.00
Previous Close 1,633.00
Day's Range 1,648.00 - 1,838.00
52-Week Range 1,338.00 - 2,320.00
Beta 1.05
RSI 36.89
Earnings Date n/a

About SAMSUNG PHARM. Co., LTD.

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, enzyme, mixed vitamins, antibiotics, and others. The company also provides medicines for the digestive system, medicines for liver disorders, medicines for the circulation ... [Read more]

Sector Healthcare
Founded 1929
Employees 240
Stock Exchange Korea Stock Exchange
Ticker Symbol 001360
Full Company Profile

Financial Performance

In 2024, SAMSUNG PHARM. Co., LTD.'s revenue was 44.29 billion, a decrease of -14.75% compared to the previous year's 51.96 billion. Earnings were 12.71 billion, a decrease of -48.77%.

Financial Statements

News

There is no news available yet.